Nicholas J. Landau Quoted in BioWorld Insight

Nicholas J. Landau, practicing in the firm’s Intellectual Property Group, was quoted in the August 27, 2012, issue of BioWorld Insight. Dr. Landau provided his thoughts on possible next steps for the Association for Molecular Pathology now that the U.S. Court of Appeals for the Federal Circuit’s has upheld the validity of Myriad Genetics Inc.’s patent claims based on the composition of isolated DNA.